Abstract
Impaired myocardial flow reserve (MFR) has been demonstrated in hypertension, and has been associated with peripheral vascular changes. We investigated whether MFR was impaired and associated with structural and/or functional vascular changes in hypertensive patients without evidence of coronary artery disease (CAD). We measured left ventricular (LV) mass index by echocardiography and MFR by positron emission tomography in 33 unmedicated, hypertensive patients with electrocardiographic LV hypertrophy without CAD, and 15 age- and gender-matched normotensive subjects. We also measured 24-h ambulatory blood pressure, minimal forearm vascular resistance (MFVR) by plethysmography, media:lumen ratio in isolated, subcutaneous resistance arteries by myography, intima–media cross-sectional area of the common carotid artery, and flow-mediated (FMD) and nitroglycerin-induced dilatation (NID) of the brachial artery by ultrasound. Compared to the controls, the patients had impaired MFR (2.4 (95% CI 1.95–2.8) vs 3.4 (2.7–4.2), P<0.01) due to increased resting myocardial blood flow (MBF) (0.82 (0.73–0.91) vs 0.65 (0.56–0.75) ml/g min), and decreased dipyridamole-stimulated MBF (1.80 (1.55–2.1) vs 2.3 (1.80–2.8) ml/g min, both P<0.05). The difference in resting MBF disappeared (80 (74–87) vs 86 (74–97) μl/kg mmHg, NS) when normalized for blood pressure and heart rate. MFR correlated negatively to median 24-h systolic blood pressure (r=−0.50, P<0.01) as well as to LV mass index (r=−0.45, P<0.05) and MFVR in men (r=−0.47, P<0.05), and positively to FMD (r=0.44, P<0.05) and NID (r=0.40, P<0.05). Hypertensive patients with electrocardiographic LV hypertrophy without CAD had impaired MFR associated with cardiovascular hypertrophy and vasodilatory dysfunction. This suggests that MFR is impaired by LV hypertrophy and structural/functional vascular damage in the coronary and noncoronary circulation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Liao Y et al. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 1997; 29: 641–647.
Vogt M, Motz W, Scheler S, Strauer BE . Disorders of coronary microcirculation and arrhythmias in systemic arterial hypertension. Am J Cardiol 1990; 65: 45G–50G.
Motz W, Scheler S, Schwartzkopff B, Strauer BE . Evaluation of cardiac damage in hypertension. J Cardiovasc Risk 1995; 2: 16–26.
Kozakova M et al. Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography. Hypertension 1997; 29: 551–559.
Roman MJ et al. Parallel cardiac and vascular adaptation in hypertension. Circulation 1992; 86: 1909–1918.
Heagerty AM et al. Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension 1993; 21: 391–397.
Shore AC, Tooke JE . Microvascular function in human essential hypertension. J Hypertens 1994; 12: 717–728.
Li J et al. Non-invasive detection of endothelial dysfunction in patients with essential hypertension. Int J Cardiol 1997; 61: 165–169.
Panza JA, Quyyumi AA, Brush Jr JE, Epstein SE . Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22–27.
Falloon BJ, Heagerty AM . In vitro perfusion studies of human resistance artery function in essential hypertension. Hypertension 1994; 24: 16–23.
Lekakis JP et al. Peripheral vascular endothelial dysfunction in patients with angina pectoris and normal coronary arteriograms. J Am Coll Cardiol 1998; 31: 541–546.
Sax FL, Cannon III RO, Hanson C, Epstein SE . Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function? N Engl J Med 1987; 317: 1366–1370.
Leschke M et al. Reduced peripheral and coronary vasomotion in systemic hypertension. Eur Heart J 1992; 13 (Suppl D): 96–99.
Olsen MH et al. Relative influence of insulin resistance versus blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE sub study. Insulin Carotids US Scandinavia. J Hypertens 2000; 18: 75–81.
Dahlof B et al. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. Hypertension 1998; 32: 989–997.
WHO. WHO Technical Reports Series 727, 1985, p. 9.
Howard G et al. Carotid artery intimal–medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 1993; 24: 1297–1304.
Folkow B . Physiological aspects of primary hypertension. Physiol Rev 1982; 62: 347–504.
Cooper KE, Edholm OG, Mottram RF . The blood flow in skin and muscle of the human forearm. J Physiol 1955; 128: 258–267.
Utriainen T, Malmstrom R, Makimattila S, Yki-Jarvinen H . Methodological aspects, dose–response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia 1995; 38: 555–564.
Palmieri V et al. Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective randomized study evaluating regression of ventricular enlargement. J Am Coll Cardiol 1999; 34: 1625–1632.
Mulvany MJ, Halpern W . Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41: 19–26.
Imai Y et al. The accuracy and performance of the A&D TM 2421, a new ambulatory blood pressure monitoring device based on the cuff-oscillometric method and the Korotkoff sound technique. Am J Hypertens 1992; 5: 719–726.
Conway J, Coats A . Value of ambulatory blood pressure monitoring in clinical pharmacology. J Hypertens Suppl 1989; 7: S29–S32.
Kuhle WG et al. Quantification of regional myocardial blood flow using 13N-ammonia and reoriented dynamic positron emission tomographic imaging. Circulation 1992; 86: 1004–1017.
Rossen JD, Simonetti I, Marcus ML, Winniford MD . Coronary dilation with standard dose dipyridamole and dipyridamole combined with handgrip. Circulation 1989; 79: 566–572.
Wilson RF et al. Effects of adenosine on human coronary arterial circulation. Circulation 1990; 82: 1595–1606.
Czernin J et al. Effects of modified pharmacologic stress approaches on hyperemic myocardial blood flow. J Nucl Med 1995; 36: 575–580.
Chan SY et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol 1992; 20: 979–985.
Joannides R et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91: 1314–1319.
Iversen HK et al. Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide-mononitrate. Eur J Clin Pharmacol 1992; 42: 31–35.
Olsen MH et al. Vasodilatory capacity and vascular structure in long-standing hypertension: a LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension. Am J Hypertension 2002; 15: 398–404.
Tadaoka S et al. Effect of left ventricular hypertrophy secondary to systemic hypertension on left coronary artery flow dynamics. Cardiovasc Res 1991; 25: 955–964.
Vogt M, Motz W, Strauer BE . Coronary haemodynamics in hypertensive heart disease. Eur Heart J 1992; 13 (Suppl D): 44–49.
Pedrinelli R et al. Myocardial and forearm blood flow reserve in mild–moderate essential hypertensive patients. J Hypertens 1997; 15: 667–673.
Buus NH et al. Reduced vasodilator capacity in syndrome X related to structure and function of resistance arteries. Am J Cardiol 1999; 83: 149–154.
Anderson TJ et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235–1241.
Pitkanen OP et al. Coronary flow reserve is reduced in young men with IDDM. Diabetes 1998; 47: 248–254.
Acknowledgements
We thank Paulette A Lyle for assistance with preparation of the manuscript. This work was supported in part by Grants from Merck & Co., Inc., Copenhagen, Denmark, and The Danish Medical Association Research Fund, Copenhagen, Denmark, as part of the LIFE ICARUS substudy.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Olsen, M., Wachtell, K., Meyer, C. et al. Association between vascular dysfunction and reduced myocardial flow reserve in patients with hypertension: a LIFE substudy. J Hum Hypertens 18, 445–452 (2004). https://doi.org/10.1038/sj.jhh.1001716
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001716
Keywords
This article is cited by
-
SPECT myocardial blood flow quantitation for the detection of angiographic stenoses with cardiac-dedicated CZT SPECT
Journal of Nuclear Cardiology (2023)
-
Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy
Current Hypertension Reports (2020)
-
Non-invasive Risk Stratification for Coronary Artery Disease: Is It Time for Subclassifications?
Current Cardiology Reports (2019)
-
β2-adrenergic stress evaluation of coronary endothelial-dependent vasodilator function in mice using 11C-acetate micro-PET imaging of myocardial blood flow and oxidative metabolism
EJNMMI Research (2014)
-
Is there an association between hypertension and the development of coronary collateral flow?
Journal of Human Hypertension (2005)